The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
this would be a great question for someone like Josh Knowles who's such an expert in FH but has anybody looked at red blood cell cholesterol membrane concentration or even size and FH patients because one hypothesis would be they especially the FH patients who have FH as a result LDL receptor deficiencies in some sort you'd think that there'd be more free diffusion of cholesterol from their LDL into their red blood cell
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.